Breaking News

Sanofi Launches Dedicated mRNA Vaccines CoE

Approximately €400million investment annually aims to accelerate end-to-end R&D of next-generation vaccines.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi is investing approximately €400 million annually in a vaccines mRNA Center of Excellence. The CoE aims to accelerate the development and delivery of next-gen vaccines by bringing together approximately 400 employees integrating mRNA capabilities with dedicated R&D, digital, and chemistry, manufacturing and controls (CMC) teams across sites at Cambridge, MA and Lyon, France.         “During the COVID-19 pandemic, mRNA technologies demonstrated potential to deliver new vaccines faster...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters